Forecast & Rating3 analysts currently cover Innate Pharma SA, of which 3 give a positive rating. The average price target is $6.67, about 214.5% upside from the current price of $2.12. Coverage is limited, so the data is for reference only. Data as of Aug 31, 2026; this does not constitute investment advice.
Aug 28, 2026Price forecast
$6.67214.47%
Forecast & RatingStrong buy
3analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 31, 2026
Forecast met0.0%
Stock price$2.12
Avg. target$5.2
High target$8
Low target$2
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.